Summary
According to APO Research, the global Anti-Infectives market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Anti-Infectives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Anti-Infectives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Anti-Infectives market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Anti-Infectives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Anti-Infectives market include Astra Zeneca plc, Glaxo SmithKline plc, Novartis, Wockhardt ltd, Pfizer, Roche, Merck, Johnson & Johnson and Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Anti-Infectives, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Anti-Infectives, also provides the sales of main regions and countries. Of the upcoming market potential for Anti-Infectives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anti-Infectives sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Anti-Infectives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Anti-Infectives sales, projected growth trends, production technology, application and end-user industry.
Anti-Infectives Segment by Company
Astra Zeneca plc
Glaxo SmithKline plc
Novartis
Wockhardt ltd
Pfizer
Roche
Merck
Johnson & Johnson
Sanofi
Anti-Infectives Segment by Type
Antifungal
Antibacterial
Antiviral
Anti-Infectives Segment by Application
Retail Pharmacies
Mail Order Pharmacies
Hospital Pharmacies
Anti-Infectives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Anti-Infectives status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Anti-Infectives market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Anti-Infectives significant trends, drivers, influence factors in global and regions.
6. To analyze Anti-Infectives competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Infectives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Anti-Infectives market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-Infectives industry.
Chapter 3: Detailed analysis of Anti-Infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Anti-Infectives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Anti-Infectives in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
- Market Overview
- Product Definition
- Global Market Growth Prospects
- Global Anti-Infectives Sales Value (2020-2031)
- Global Anti-Infectives Sales Volume (2020-2031)
- Global Anti-Infectives Sales Average Price (2020-2031)
- Assumptions and Limitations
- Study Goals and Objectives
- Anti-Infectives Market Dynamics
- Anti-Infectives Industry Trends
- Anti-Infectives Industry Drivers
- Anti-Infectives Industry Opportunities and Challenges
- Anti-Infectives Industry Restraints
- Anti-Infectives Market by Company
- Global Anti-Infectives Company Revenue Ranking in 2024
- Global Anti-Infectives Revenue by Company (2020-2025)
- Global Anti-Infectives Sales Volume by Company (2020-2025)
- Global Anti-Infectives Average Price by Company (2020-2025)
- Global Anti-Infectives Company Ranking (2023-2025)
- Global Anti-Infectives Company Manufacturing Base and Headquarters
- Global Anti-Infectives Company Product Type and Application
- Global Anti-Infectives Company Establishment Date
- Market Competitive Analysis
- Global Anti-Infectives Market Concentration Ratio (CR5 and HHI)
- Global Top 5 and 10 Company Market Share by Revenue in 2024
- 2024 Anti-Infectives Tier 1, Tier 2, and Tier 3 Companies
- Mergers and Acquisitions Expansion
- Anti-Infectives Market by Type
- Anti-Infectives Type Introduction
- Antifungal
- Antibacterial
- Antiviral
- Global Anti-Infectives Sales Volume by Type
- Global Anti-Infectives Sales Volume by Type (2020 VS 2024 VS 2031)
- Global Anti-Infectives Sales Volume by Type (2020-2031)
- Global Anti-Infectives Sales Volume Share by Type (2020-2031)
- Global Anti-Infectives Sales Value by Type
- Global Anti-Infectives Sales Value by Type (2020 VS 2024 VS 2031)
- Global Anti-Infectives Sales Value by Type (2020-2031)
- Global Anti-Infectives Sales Value Share by Type (2020-2031)
- Anti-Infectives Type Introduction
- Anti-Infectives Market by Application
- Anti-Infectives Application Introduction
- Retail Pharmacies
- Mail Order Pharmacies
- Hospital Pharmacies
- Global Anti-Infectives Sales Volume by Application
- Global Anti-Infectives Sales Volume by Application (2020 VS 2024 VS 2031)
- Global Anti-Infectives Sales Volume by Application (2020-2031)
- Global Anti-Infectives Sales Volume Share by Application (2020-2031)
- Global Anti-Infectives Sales Value by Application
- Global Anti-Infectives Sales Value by Application (2020 VS 2024 VS 2031)
- Global Anti-Infectives Sales Value by Application (2020-2031)
- Global Anti-Infectives Sales Value Share by Application (2020-2031)
- Anti-Infectives Application Introduction
- Anti-Infectives Regional Sales and Value Analysis
- Global Anti-Infectives Sales by Region: 2020 VS 2024 VS 2031
- Global Anti-Infectives Sales by Region (2020-2031)
- Global Anti-Infectives Sales by Region: 2020-2025
- Global Anti-Infectives Sales by Region (2026-2031)
- Global Anti-Infectives Sales Value by Region: 2020 VS 2024 VS 2031
- Global Anti-Infectives Sales Value by Region (2020-2031)
- Global Anti-Infectives Sales Value by Region: 2020-2025
- Global Anti-Infectives Sales Value by Region (2026-2031)
- Global Anti-Infectives Market Price Analysis by Region (2020-2025)
- North America
- North America Anti-Infectives Sales Value (2020-2031)
- North America Anti-Infectives Sales Value Share by Country, 2024 VS 2031
- Europe
- Europe Anti-Infectives Sales Value (2020-2031)
- Europe Anti-Infectives Sales Value Share by Country, 2024 VS 2031
- Asia-Pacific
- Asia-Pacific Anti-Infectives Sales Value (2020-2031)
- Asia-Pacific Anti-Infectives Sales Value Share by Country, 2024 VS 2031
- South America
- South America Anti-Infectives Sales Value (2020-2031)
- South America Anti-Infectives Sales Value Share by Country, 2024 VS 2031
- Middle East & Africa
- Middle East & Africa Anti-Infectives Sales Value (2020-2031)
- Middle East & Africa Anti-Infectives Sales Value Share by Country, 2024 VS 2031
- Anti-Infectives Country-level Sales and Value Analysis
- Global Anti-Infectives Sales by Country: 2020 VS 2024 VS 2031
- Global Anti-Infectives Sales Value by Country: 2020 VS 2024 VS 2031
- Global Anti-Infectives Sales by Country (2020-2031)
- Global Anti-Infectives Sales by Country (2020-2025)
- Global Anti-Infectives Sales by Country (2026-2031)
- Global Anti-Infectives Sales Value by Country (2020-2031)
- Global Anti-Infectives Sales Value by Country (2020-2025)
- Global Anti-Infectives Sales Value by Country (2026-2031)
- USA
- USA Anti-Infectives Sales Value Growth Rate (2020-2031)
- USA Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- USA Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Canada
- Canada Anti-Infectives Sales Value Growth Rate (2020-2031)
- Canada Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Canada Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Mexico
- Mexico Anti-Infectives Sales Value Growth Rate (2020-2031)
- Mexico Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Mexico Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Germany
- Germany Anti-Infectives Sales Value Growth Rate (2020-2031)
- Germany Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Germany Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- France
- France Anti-Infectives Sales Value Growth Rate (2020-2031)
- France Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- France Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- U.K.
- U.K. Anti-Infectives Sales Value Growth Rate (2020-2031)
- U.K. Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- U.K. Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Italy
- Italy Anti-Infectives Sales Value Growth Rate (2020-2031)
- Italy Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Italy Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Spain
- Spain Anti-Infectives Sales Value Growth Rate (2020-2031)
- Spain Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Spain Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Russia
- Russia Anti-Infectives Sales Value Growth Rate (2020-2031)
- Russia Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Russia Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Netherlands
- Netherlands Anti-Infectives Sales Value Growth Rate (2020-2031)
- Netherlands Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Netherlands Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Nordic Countries
- Nordic Countries Anti-Infectives Sales Value Growth Rate (2020-2031)
- Nordic Countries Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Nordic Countries Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- China
- China Anti-Infectives Sales Value Growth Rate (2020-2031)
- China Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- China Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Japan
- Japan Anti-Infectives Sales Value Growth Rate (2020-2031)
- Japan Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Japan Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- South Korea
- South Korea Anti-Infectives Sales Value Growth Rate (2020-2031)
- South Korea Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- South Korea Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- India
- India Anti-Infectives Sales Value Growth Rate (2020-2031)
- India Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- India Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Australia
- Australia Anti-Infectives Sales Value Growth Rate (2020-2031)
- Australia Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Australia Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Southeast Asia
- Southeast Asia Anti-Infectives Sales Value Growth Rate (2020-2031)
- Southeast Asia Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Southeast Asia Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Brazil
- Brazil Anti-Infectives Sales Value Growth Rate (2020-2031)
- Brazil Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Brazil Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Argentina
- Argentina Anti-Infectives Sales Value Growth Rate (2020-2031)
- Argentina Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Argentina Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Chile
- Chile Anti-Infectives Sales Value Growth Rate (2020-2031)
- Chile Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Chile Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Colombia
- Colombia Anti-Infectives Sales Value Growth Rate (2020-2031)
- Colombia Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Colombia Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Peru
- Peru Anti-Infectives Sales Value Growth Rate (2020-2031)
- Peru Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Peru Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Saudi Arabia
- Saudi Arabia Anti-Infectives Sales Value Growth Rate (2020-2031)
- Saudi Arabia Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Saudi Arabia Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Israel
- Israel Anti-Infectives Sales Value Growth Rate (2020-2031)
- Israel Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Israel Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- UAE
- UAE Anti-Infectives Sales Value Growth Rate (2020-2031)
- UAE Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- UAE Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Turkey
- Turkey Anti-Infectives Sales Value Growth Rate (2020-2031)
- Turkey Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Turkey Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Iran
- Iran Anti-Infectives Sales Value Growth Rate (2020-2031)
- Iran Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Iran Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Egypt
- Egypt Anti-Infectives Sales Value Growth Rate (2020-2031)
- Egypt Anti-Infectives Sales Value Share by Type, 2024 VS 2031
- Egypt Anti-Infectives Sales Value Share by Application, 2024 VS 2031
- Company Profiles
- Astra Zeneca plc
- Astra Zeneca plc Comapny Information
- Astra Zeneca plc Business Overview
- Astra Zeneca plc Anti-Infectives Sales, Value and Gross Margin (2020-2025)
- Astra Zeneca plc Anti-Infectives Product Portfolio
- Astra Zeneca plc Recent Developments
- Glaxo SmithKline plc
- Glaxo SmithKline plc Comapny Information
- Glaxo SmithKline plc Business Overview
- Glaxo SmithKline plc Anti-Infectives Sales, Value and Gross Margin (2020-2025)
- Glaxo SmithKline plc Anti-Infectives Product Portfolio
- Glaxo SmithKline plc Recent Developments
- Novartis
- Novartis Comapny Information
- Novartis Business Overview
- Novartis Anti-Infectives Sales, Value and Gross Margin (2020-2025)
- Novartis Anti-Infectives Product Portfolio
- Novartis Recent Developments
- Wockhardt ltd
- Wockhardt ltd Comapny Information
- Wockhardt ltd Business Overview
- Wockhardt ltd Anti-Infectives Sales, Value and Gross Margin (2020-2025)
- Wockhardt ltd Anti-Infectives Product Portfolio
- Wockhardt ltd Recent Developments
- Pfizer
- Pfizer Comapny Information
- Pfizer Business Overview
- Pfizer Anti-Infectives Sales, Value and Gross Margin (2020-2025)
- Pfizer Anti-Infectives Product Portfolio
- Pfizer Recent Developments
- Roche
- Roche Comapny Information
- Roche Business Overview
- Roche Anti-Infectives Sales, Value and Gross Margin (2020-2025)
- Roche Anti-Infectives Product Portfolio
- Roche Recent Developments
- Merck
- Merck Comapny Information
- Merck Business Overview
- Merck Anti-Infectives Sales, Value and Gross Margin (2020-2025)
- Merck Anti-Infectives Product Portfolio
- Merck Recent Developments
- Johnson & Johnson
- Johnson & Johnson Comapny Information
- Johnson & Johnson Business Overview
- Johnson & Johnson Anti-Infectives Sales, Value and Gross Margin (2020-2025)
- Johnson & Johnson Anti-Infectives Product Portfolio
- Johnson & Johnson Recent Developments
- Sanofi
- Sanofi Comapny Information
- Sanofi Business Overview
- Sanofi Anti-Infectives Sales, Value and Gross Margin (2020-2025)
- Sanofi Anti-Infectives Product Portfolio
- Sanofi Recent Developments
- Astra Zeneca plc
- Value Chain and Sales Channels Analysis
- Anti-Infectives Value Chain Analysis
- Anti-Infectives Key Raw Materials
- Raw Materials Key Suppliers
- Manufacturing Cost Structure
- Anti-Infectives Sales Mode & Process
- Anti-Infectives Sales Channels Analysis
- Direct Comparison with Distribution Share
- Anti-Infectives Distributors
- Anti-Infectives Customers
- Anti-Infectives Value Chain Analysis
- Concluding Insights
- Appendix
- Reasons for Doing This Study
- Research Methodology
- Research Process
- Authors List of This Report
- Data Source
- Secondary Sources
- Primary Sources
List of Tables
Table 1 | :Anti-Infectives Industry Trends |
Table 2 | :Anti-Infectives Industry Drivers |
Table 3 | :Anti-Infectives Industry Opportunities and Challenges |
Table 4 | :Anti-Infectives Industry Restraints |
Table 5 | :Global Anti-Infectives Revenue by Company (US$ Million) & (2020-2025) |
Table 6 | :Global Anti-Infectives Revenue Share by Company (2020-2025) |
Table 7 | :Global Anti-Infectives Sales Volume by Company (W Units) & (2020-2025) |
Table 8 | :Global Anti-Infectives Sales Volume Share by Company (2020-2025) |
Table 9 | :Global Anti-Infectives Average Price (US$/Unit) of Company (2020-2025) |
Table 10 | :Global Anti-Infectives Company Ranking, (2023-2025) & (USD Million) |
Table 11 | :Global Anti-Infectives Key Company Manufacturing Base & Headquarters |
Table 12 | :Global Anti-Infectives Company, Product Type & Application |
Table 13 | :Global Anti-Infectives Company Establishment Date |
Table 14 | :Global Company Market Concentration Ratio (CR5 and HHI) |
Table 15 | :Global Anti-Infectives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2024) |
Table 16 | :Mergers & Acquisitions, Expansion |
Table 17 | :Significant Companies of Antifungal |
Table 18 | :Significant Companies of Antibacterial |
Table 19 | :Significant Companies of Antiviral |
Table 20 | :Global Anti-Infectives Sales Volume by Type 2020 VS 2024 VS 2031 (W Units) |
Table 21 | :Global Anti-Infectives Sales Volume by Type (2020-2025) & (W Units) |
Table 22 | :Global Anti-Infectives Sales Volume by Type (2026-2031) & (W Units) |
Table 23 | :Global Anti-Infectives Sales Volume Share by Type (2020-2025) |
Table 24 | :Global Anti-Infectives Sales Volume Share by Type (2026-2031) |
Table 25 | :Global Anti-Infectives Sales Value by Type 2020 VS 2024 VS 2031 (US$ Million) |
Table 26 | :Global Anti-Infectives Sales Value by Type (2020-2025) & (US$ Million) |
Table 27 | :Global Anti-Infectives Sales Value by Type (2026-2031) & (US$ Million) |
Table 28 | :Global Anti-Infectives Sales Value Share by Type (2020-2025) |
Table 29 | :Global Anti-Infectives Sales Value Share by Type (2026-2031) |
Table 30 | :Significant Companies of Retail Pharmacies |
Table 31 | :Significant Companies of Mail Order Pharmacies |
Table 32 | :Significant Companies of Hospital Pharmacies |
Table 33 | :Global Anti-Infectives Sales Volume by Application 2020 VS 2024 VS 2031 (W Units) |
Table 34 | :Global Anti-Infectives Sales Volume by Application (2020-2025) & (W Units) |
Table 35 | :Global Anti-Infectives Sales Volume by Application (2026-2031) & (W Units) |
Table 36 | :Global Anti-Infectives Sales Volume Share by Application (2020-2025) |
Table 37 | :Global Anti-Infectives Sales Volume Share by Application (2026-2031) |
Table 38 | :Global Anti-Infectives Sales Value by Application 2020 VS 2024 VS 2031 (US$ Million) |
Table 39 | :Global Anti-Infectives Sales Value by Application (2020-2025) & (US$ Million) |
Table 40 | :Global Anti-Infectives Sales Value by Application (2026-2031) & (US$ Million) |
Table 41 | :Global Anti-Infectives Sales Value Share by Application (2020-2025) |
Table 42 | :Global Anti-Infectives Sales Value Share by Application (2026-2031) |
Table 43 | :Global Anti-Infectives Sales by Region: 2020 VS 2024 VS 2031 (W Units) |
Table 44 | :Global Anti-Infectives Sales by Region (2020-2025) & (W Units) |
Table 45 | :Global Anti-Infectives Sales Market Share by Region (2020-2025) |
Table 46 | :Global Anti-Infectives Sales by Region (2026-2031) & (W Units) |
Table 47 | :Global Anti-Infectives Sales Market Share by Region (2026-2031) |
Table 48 | :Global Anti-Infectives Sales Value Comparison by Region: 2020 VS 2024 VS 2031 (US$ Million) |
Table 49 | :Global Anti-Infectives Sales Value by Region (2020-2025) & (US$ Million) |
Table 50 | :Global Anti-Infectives Sales Value Share by Region (2020-2025) |
Table 51 | :Global Anti-Infectives Sales Value by Region (2026-2031) & (US$ Million) |
Table 52 | :Global Anti-Infectives Sales Value Share by Region (2026-2031) |
Table 53 | :Global Anti-Infectives Market Average Price (US$/Unit) by Region (2020-2025) |
Table 54 | :Global Anti-Infectives Market Average Price (US$/Unit) by Region (2026-2031) |
Table 55 | :Global Anti-Infectives Sales by Country: 2020 VS 2024 VS 2031 (W Units) |
Table 56 | :Global Anti-Infectives Sales Value by Country: 2020 VS 2024 VS 2031 (US$ Million) |
Table 57 | :Global Anti-Infectives Sales by Country (2020-2025) & (W Units) |
Table 58 | :Global Anti-Infectives Sales Market Share by Country (2020-2025) |
Table 59 | :Global Anti-Infectives Sales by Country (2026-2031) & (W Units) |
Table 60 | :Global Anti-Infectives Sales Market Share by Country (2026-2031) |
Table 61 | :Global Anti-Infectives Sales Value by Country (2020-2025) & (US$ Million) |
Table 62 | :Global Anti-Infectives Sales Value Market Share by Country (2020-2025) |
Table 63 | :Global Anti-Infectives Sales Value by Country (2026-2031) & (US$ Million) |
Table 64 | :Global Anti-Infectives Sales Value Market Share by Country (2026-2031) |
Table 65 | :Astra Zeneca plc Company Information |
Table 66 | :Astra Zeneca plc Business Overview |
Table 67 | :Astra Zeneca plc Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 68 | :Astra Zeneca plc Anti-Infectives Product Portfolio |
Table 69 | :Astra Zeneca plc Recent Development |
Table 70 | :Glaxo SmithKline plc Company Information |
Table 71 | :Glaxo SmithKline plc Business Overview |
Table 72 | :Glaxo SmithKline plc Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 73 | :Glaxo SmithKline plc Anti-Infectives Product Portfolio |
Table 74 | :Glaxo SmithKline plc Recent Development |
Table 75 | :Novartis Company Information |
Table 76 | :Novartis Business Overview |
Table 77 | :Novartis Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 78 | :Novartis Anti-Infectives Product Portfolio |
Table 79 | :Novartis Recent Development |
Table 80 | :Wockhardt ltd Company Information |
Table 81 | :Wockhardt ltd Business Overview |
Table 82 | :Wockhardt ltd Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 83 | :Wockhardt ltd Anti-Infectives Product Portfolio |
Table 84 | :Wockhardt ltd Recent Development |
Table 85 | :Pfizer Company Information |
Table 86 | :Pfizer Business Overview |
Table 87 | :Pfizer Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 88 | :Pfizer Anti-Infectives Product Portfolio |
Table 89 | :Pfizer Recent Development |
Table 90 | :Roche Company Information |
Table 91 | :Roche Business Overview |
Table 92 | :Roche Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 93 | :Roche Anti-Infectives Product Portfolio |
Table 94 | :Roche Recent Development |
Table 95 | :Merck Company Information |
Table 96 | :Merck Business Overview |
Table 97 | :Merck Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 98 | :Merck Anti-Infectives Product Portfolio |
Table 99 | :Merck Recent Development |
Table 100 | :Johnson & Johnson Company Information |
Table 101 | :Johnson & Johnson Business Overview |
Table 102 | :Johnson & Johnson Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 103 | :Johnson & Johnson Anti-Infectives Product Portfolio |
Table 104 | :Johnson & Johnson Recent Development |
Table 105 | :Sanofi Company Information |
Table 106 | :Sanofi Business Overview |
Table 107 | :Sanofi Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 108 | :Sanofi Anti-Infectives Product Portfolio |
Table 109 | :Sanofi Recent Development |
Table 110 | :Key Raw Materials |
Table 111 | :Raw Materials Key Suppliers |
Table 112 | :Anti-Infectives Distributors List |
Table 113 | :Anti-Infectives Customers List |
Table 114 | :Research Programs/Design for This Report |
Table 115 | :Authors List of This Report |
Table 116 | :Secondary Sources |
Table 117 | :Primary Sources |
List of Figures
Figure 1 | :Anti-Infectives Product Image |
Figure 2 | :Global Anti-Infectives Sales Value (US$ Million), 2020 VS 2024 VS 2031 |
Figure 3 | :Global Anti-Infectives Sales Value (2020-2031) & (US$ Million) |
Figure 4 | :Global Anti-Infectives Sales (2020-2031) & (W Units) |
Figure 5 | :Global Anti-Infectives Sales Average Price (US$/Unit) & (2020-2031) |
Figure 6 | :Global Anti-Infectives Company Revenue Ranking in 2024 (US$ Million) |
Figure 7 | :Global Top 5 and 10 Company Market Share by Revenue in 2024 (US$ Million) |
Figure 8 | :Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024 |
Figure 9 | :Antifungal Image |
Figure 10 | :Antibacterial Image |
Figure 11 | :Antiviral Image |
Figure 12 | :Global Anti-Infectives Sales Volume by Type (2020 VS 2024 VS 2031) & (W Units) |
Figure 13 | :Global Anti-Infectives Sales Volume Share 2020 VS 2024 VS 2031 |
Figure 14 | :Global Anti-Infectives Sales Volume Share by Type (2020-2031) |
Figure 15 | :Global Anti-Infectives Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million) |
Figure 16 | :Global Anti-Infectives Sales Value Share 2020 VS 2024 VS 2031 |
Figure 17 | :Global Anti-Infectives Sales Value Share by Type (2020-2031) |
Figure 18 | :Retail Pharmacies Image |
Figure 19 | :Mail Order Pharmacies Image |
Figure 20 | :Hospital Pharmacies Image |
Figure 21 | :Global Anti-Infectives Sales Volume by Application (2020 VS 2024 VS 2031) & (W Units) |
Figure 22 | :Global Anti-Infectives Sales Volume Share 2020 VS 2024 VS 2031 |
Figure 23 | :Global Anti-Infectives Sales Volume Share by Application (2020-2031) |
Figure 24 | :Global Anti-Infectives Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million) |
Figure 25 | :Global Anti-Infectives Sales Value Share 2020 VS 2024 VS 2031 |
Figure 26 | :Global Anti-Infectives Sales Value Share by Application (2020-2031) |
Figure 27 | :Global Anti-Infectives Sales by Region: 2020 VS 2024 VS 2031 (W Units) |
Figure 28 | :Global Anti-Infectives Sales Market Share by Region: 2020 VS 2024 VS 2031 |
Figure 29 | :Global Anti-Infectives Sales Value Comparison by Region: 2020 VS 2024 VS 2031 (US$ Million) |
Figure 30 | :Global Anti-Infectives Sales Value Share by Region: 2020 VS 2024 VS 2031 |
Figure 31 | :North America Anti-Infectives Sales Value (2020-2031) & (US$ Million) |
Figure 32 | :North America Anti-Infectives Sales Value Share by Country (%), 2024 VS 2031 |
Figure 33 | :Europe Anti-Infectives Sales Value (2020-2031) & (US$ Million) |
Figure 34 | :Europe Anti-Infectives Sales Value Share by Country (%), 2024 VS 2031 |
Figure 35 | :Asia-Pacific Anti-Infectives Sales Value (2020-2031) & (US$ Million) |
Figure 36 | :Asia-Pacific Anti-Infectives Sales Value Share by Country (%), 2024 VS 2031 |
Figure 37 | :South America Anti-Infectives Sales Value (2020-2031) & (US$ Million) |
Figure 38 | :South America Anti-Infectives Sales Value Share by Country (%), 2024 VS 2031 |
Figure 39 | :Middle East & Africa Anti-Infectives Sales Value (2020-2031) & (US$ Million) |
Figure 40 | :Middle East & Africa Anti-Infectives Sales Value Share by Country (%), 2024 VS 2031 |
Figure 41 | :USA Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 42 | :USA Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 43 | :USA Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 44 | :Canada Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 45 | :Canada Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 46 | :Canada Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 47 | :Mexico Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 48 | :Mexico Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 49 | :Mexico Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 50 | :Germany Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 51 | :Germany Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 52 | :Germany Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 53 | :France Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 54 | :France Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 55 | :France Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 56 | :U.K. Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 57 | :U.K. Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 58 | :U.K. Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 59 | :Italy Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 60 | :Italy Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 61 | :Italy Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 62 | :Spain Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 63 | :Spain Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 64 | :Spain Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 65 | :Russia Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 66 | :Russia Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 67 | :Russia Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 68 | :Netherlands Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 69 | :Netherlands Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 70 | :Netherlands Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 71 | :Nordic Countries Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 72 | :Nordic Countries Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 73 | :Nordic Countries Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 74 | :China Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 75 | :China Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 76 | :China Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 77 | :Japan Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 78 | :Japan Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 79 | :Japan Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 80 | :South Korea Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 81 | :South Korea Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 82 | :South Korea Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 83 | :India Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 84 | :India Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 85 | :India Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 86 | :Australia Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 87 | :Australia Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 88 | :Australia Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 89 | :Southeast Asia Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 90 | :Southeast Asia Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 91 | :Southeast Asia Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 92 | :Brazil Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 93 | :Brazil Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 94 | :Brazil Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 95 | :Argentina Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 96 | :Argentina Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 97 | :Argentina Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 98 | :Chile Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 99 | :Chile Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 100 | :Chile Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 101 | :Colombia Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 102 | :Colombia Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 103 | :Colombia Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 104 | :Peru Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 105 | :Peru Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 106 | :Peru Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 107 | :Saudi Arabia Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 108 | :Saudi Arabia Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 109 | :Saudi Arabia Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 110 | :Israel Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 111 | :Israel Arabia Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 112 | :Israel Arabia Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 113 | :UAE Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 114 | :UAE Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 115 | :UAE Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 116 | :Turkey Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 117 | :Turkey Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 118 | :Turkey Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 119 | :Iran Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 120 | :Iran Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 121 | :Iran Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 122 | :Egypt Anti-Infectives Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 123 | :Egypt Anti-Infectives Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 124 | :Egypt Anti-Infectives Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 125 | :Anti-Infectives Value Chain |
Figure 126 | :Manufacturing Cost Structure |
Figure 127 | :Anti-Infectives Sales Mode & Process |
Figure 128 | :Direct Comparison with Distribution Share |
Figure 129 | :Distributors Profiles |
Figure 130 | :Years Considered |
Figure 131 | :Research Process |
Figure 132 | :Key Executives Interviewed |
Request a Sample
Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Pharma & Healthcare
Global Anti-Infectives Market Outlook and Growth Opportunities 2025
Pages: 195
Complete Your Request
Customer reviews
- 0 out of 5
- 0 Reviews
5
4
3
2
1
No Rating Review Exist.
Write Review
Suggested Report
View MoreNo data found.